Patriot Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Patriot Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$6.66M	Sell	69,015 -1,267	-2%	-$134K	0.97%	42
2018 Q3	$8.57M	Buy	70,282 +1,538	+2%	+$181K	1.08%	38
2018 Q2	$7.55M	Buy	68,744 +1,627	+2%	+$174K	1.04%	38
2018 Q1	$7.16M	Buy	67,117 +23,564	+54%	+$2.61M	1.02%	34
2017 Q4	$4.65M	Buy	+43,553	New	+$4.66M	0.66%	56
2017 Q3	–	Sell	-77,931	Closed	-$8.05M	–	79
2017 Q2	$8.05M	Buy	77,931 +2,715	+4%	+$267K	1.35%	20
2017 Q1	$7.35M	Buy	75,216 +3,255	+5%	+$312K	1.18%	29
2016 Q4	$6.37M	Buy	71,961 +3	+0%	+$273	1.2%	31
2016 Q3	$6.94M	Sell	71,958 -2,211	-3%	-$210K	1.34%	26
2016 Q2	$6.36M	Buy	74,169 +1,590	+2%	+$143K	1.26%	30
2016 Q1	$6.31M	Buy	72,579 +35,916	+98%	+$3.21M	1.27%	29
2015 Q4	$4.13M	Buy	+36,663	New	+$3.98M	0.86%	45
2015 Q2	–	Sell	-63,459	Closed	-$7.26M	–	64
2015 Q1	$7.26M	Buy	63,459 +2,388	+4%	+$263K	1.62%	19
2014 Q4	$6.17M	Buy	61,071 +1,161	+2%	+$113K	1.44%	21
2014 Q3	$5.46M	Buy	59,910 +1,494	+3%	+$131K	1.35%	24
2014 Q2	$5M	Buy	+58,416	New	+$4.6M	1.27%	30

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Patriot Wealth Management's IBB Position: Q4 2018 in Review

Patriot Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 1.8% in Q4 2018, selling an estimated $134K and leaving 69,015 shares worth $6.66M. The position accounts for 0.97% of the portfolio, ranked #42.

Patriot Wealth Management first reported a position in IBB in Q2 2014 and has held it in 16 quarters since. The position peaked at $8.57M in Q3 2018. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

Patriot Wealth Management held 69,015 shares of iShares Biotechnology ETF worth $6.66M as of Q4 2018.
Patriot Wealth Management sold 1,267 iShares Biotechnology ETF shares in Q4 2018, an estimated $134K.
iShares Biotechnology ETF made up 0.97% of Patriot Wealth Management's portfolio in Q4 2018, its #42 holding.
Patriot Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 16 quarters since.
Patriot Wealth Management's iShares Biotechnology ETF position peaked at $8.57M in Q3 2018.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on Patriot Wealth Management's 13F filing for Q4 2018, filed 7 Jan 2019.